Meghann Smith has joined Ockham as senior director, global therapeutic strategic development within the OckhamCROTM division. Smith will provide Ockham clients and functional teams with senior-level strategic guidance, risk mitigation analysis and solutions throughout the life-cycle of projects to help ensure study and program optimization on the regional, global and project/program levels with a primary therapeutic focus in hematology and oncology.

Smith previously served at PPD where she implemented senior-level program management oversight and risk mitigation strategies in all phases of study development.